Y-mAbs Therapeutics, Inc. (YMAB) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Mar-31-20	Dec-31-19	Mar-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	8-K	10-K	8-K	10-K	10-K	S-1/A
Assets
Cash and equivalents	181.6	114.6	185.8	207.1	134.2	147.8	90.5	16.9
Accounts receivable, net	7.7
Inventories	5.5
Other current assets	7.5	7.7	4.1	4.8	2.8	3.7	0.9	0.4
Total current assets	202.3	122.4	189.8	212.0	137.0	151.5	91.4	17.3
Property, plant, and equipment, net	1.8	1.8	2.0	2.1	0.4	0.2
Intangibles	1.7
Other fixed assets	3.2	3.3	0.4	0.4	0.2	0.2
Total assets	212.8	132.0	194.1	216.4	140.0	151.9	92.1	17.3

Accounts payable	13.6	9.4	10.3	8.5	5.9	5.9	5.9	2.2
Accrued expenses	12.5	8.2	4.0	4.6	3.9	3.3	2.0	0.7
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other current liabilities	1.8	2.0	0.5	0.5	0.5
Total current liabilities	27.9	19.5	14.8	13.6	10.3	9.1	7.9	3.0
Other liabilities	4.8	6.7	3.9	3.9	4.2	2.3	2.1	2.2
Total liabilities	32.7	26.2	18.7	17.5	14.5	11.4	10.0	5.2

Shareholders' equity [+]	180.1	105.8	175.3	198.9	125.5	140.5	82.2	12.1
Paid-in capital	519.2	391.6	367.3	364.7	226.2	225.4	123.9	34.4
Retained earnings	-340.5	-285.2	-192.0	-165.9	-100.8	-84.8	-41.6	-22.4
Tangible shareholders' equity	178.4	105.8	175.3	198.9	125.5	140.5	82.2	12.1